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Abstract
Introduction: In the Police Forces Hypertension, Diabetes, 
Renal Insufficiency and Thyroid Derangement (HyDRIT) 
pilot study we explored the prevalence, risk factors, 
awareness, treatment adequacy and complications of 
chronic kidney disease (CKD) and other non-communicable 
diseases among adult Police Forces households in two 
housing complexes in Khartoum, Sudan.
Methods: Serum creatinine measurements and urine 
dipstick testing were performed for 273 individuals. The 
glomerular filtration rate (GFR) was estimated using the 
standardized Cockroft-Gault and the four variable MDRD 
formulas. CKD was defined as an estimated GFR of less 
than 60 ml/min/1.73m2 and/or proteinuria. 
Results: The overall prevalence of CKD was 11% (30/273) 
using the standardized Cockroft-Gault equation and 
7.7% (21/273) using the four variable MDRD equation. 
According to the standardized Cockroft-Gault formula, 
14 subjects had reduced GFR with negative urine dipstick 
testing, two subjects had both proteinuria and reduced 
GFR, and 14 subjects had proteinuria without reduction 
in GFR. None of those subjects was aware of his kidney 
problem. According to the standardized Cockroft-Gault 
formula, 14 of the identified CKD cases were hypertensive 
(46.7%); eight of them (57.1%) had a prior diagnosis of 
hypertension but none achieved therapeutic targets. Four 
of the identified CKD cases were diabetic (13.3%), three 
of whom had a prior diagnosis of diabetes mellitus with 
reasonably controlled blood sugar levels. Only age above 
50 years and low educational level proved to be independent 
risk factors for CKD in multivariate analysis.
Conclusion: The prevalence of CKD in the study 
population seems to be comparable to other countries.
Keywords: awareness, chronic kidney disease, diabetes 
mellitus, hypertension, prevalence, Sudan
Introduction
Chronic kidney disease (CKD) is emerging as a global 
threat to human health. Screening surveys of representative 
samples of the whole population performed in the US, 
Australia, Japan and Europe have identified between 
6% and 11% as having some degree of CKD [1-4]. 
Population-based studies relating to the prevalence of 
CKD in developing countries are scarce. Several studies 
have demonstrated high incidence of CKD among black 
Americans. Unfortunately, there are no reliable statistics 
on CKD from most African countries. However, there 
is a general impression that it is at least three to four 
times more frequent than in developed countries [5]. The 
number of patients with end stage renal disease (ESRD) 
probably underestimates the entire burden of CKD 
because the numbers with earlier stages of disease are 
likely to exceed by as much as 50 times those reaching 
ESRD [1].
With the rising prevalence of its risk factors, CKD 
has become increasingly common. Diabetes mellitus 
(DM) and hypertension are major risk factors for renal 
function impairment. The association of renal disease 
and certain social and economic factors suggests that 
lack of timely preventive health care interventions 
focused on these factors may aggravate this problem. 
Individuals whose disease progresses are not only faced 
by the need for dialysis, kidney transplantation and 
shortened life expectancy, but are also at very high risk 
for cardiovascular disease [6, 7].
The global total cumulative cost for renal replacement 
therapy is 1 trillion US $. The cost and complexity of renal 
replacement therapy make it challenging for developing 
countries, which are struggling to provide preventive and 
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therapeutic measures for communicable diseases such as 
malaria, tuberculosis, AIDS and other tropical infections. 
Once recognized, simple and inexpensive treatments 
to manage the early stages of CKD proved effective to 
slow down its progression. In Sudan, there is no national 
registry for renal patients and the knowledge about the 
epidemiology of CKD is very limited. 
In this article, we display the results of the CKD survey 
of the Hypertension, Diabetes, Renal Insufficiency and 
Thyroid Derangement (HyDRIT) pilot study in Sudan. 
This study was designed as a limited population-based 
survey of the prevalence of some non-communicable 
diseases and their underlying risk factors. The general 
objective of this study was to provide insight about the 
awareness, prevalence, risk factors, treatment adequacy 
and complications of CKD and other non-communicable 
diseases among a large sample of Sudanese police forces 
households who are probably representative of the 
Sudanese population. 
Methods
This was a pilot cross-sectional community-based survey 
of police housing complexes in Greater Khartoum 
(comprising three cities; Khartoum, Omdurman and 
Khartoum North). The protocol was approved by the 
ethics committee of the National Ribat University. 
Khartoum is the capital city of Sudan with about 6 million 
inhabitants. Police housing complexes are scattered 
throughout the city. They are co-inhabited by Police 
officers and soldiers as well as their immediate, and many 
times, extended family members. They reflect people with 
average Sudanese characteristics regarding income and 
baseline demographics. They are entitled to free medical 
service, mainly provided at the Central Police Hospital 
in Khartoum. The estimated total number of inhabitants 
is seven thousands residing in 26 complexes. Phase one 
of the study was undertaken in the first two of these 
complexes, targeting about 436 individuals. All houses 
were visited and all inhabitants more than 18 years of age 
were asked to participate. 
The field visits were conducted by the senior students 
of the National Ribat University Medical School during 
October 2005. Prior to the study, students underwent 
planned training to follow a standardized protocol 
for administering the questionnaire, measuring blood 
pressure and anthropometric parameters and blood 
sampling. Experienced laboratory technicians were 
available to help with blood draws. Students were 
divided into teams of two to fill out the questionnaire 
and carry out relevant tests. Monitoring of compliance 
with the above procedures was regularly conducted by 
a physician and a social worker who frequently oversaw 
executing teams.
Informed consent was obtained from participants 
prior to recruitment. All participants underwent a 
standard interview to record demographic and lifestyle 
characteristics as well as the presence of hypertension, 
DM, and renal disease. Study participants with 
hypertension or DM were asked whether they were using, 
and if so compliant with, prescribed medications. 
Blood pressure was measured using a sphygmomanometer 
with the subject seated in a chair with his arm at the level 
of the heart. Standard mercury sphygmomanometers 
were used, and one of two cuff sizes (regular adult or 
large) were chosen based on the circumference of the 
participant's arm. Systolic and diastolic blood pressure 
was considered as Korotkoff’s phases 1 and 5 respectively. 
Two measurements were taken with at least 2 minutes 
interval between them and the average of both systolic and 
diastolic blood pressures was recorded. Hypertension was 
defined as systolic blood pressure (SBP) ≥ 140 mmHg, 
and/or diastolic blood pressure (DBP) ≥ 90 mmHg, and/
or current use of antihypertensive medications. Control 
of hypertension was defined as SBP less than 130 mmHg 
and DBP less than 80 mmHg. Underweight was defined 
as body mass index (BMI) less than 18.5 kg/m2, normal 
weight as BMI 18.5-24.9 kg/m2, overweight as BMI 
25-29.9 kg/m2, and obesity as BMI ≥ 30 kg/m2.
Participants were requested to give blood and midstream 
urine samples for analysis. Samples were transported to 
the central laboratory of the National Ribat University 
Hospital (RUH) for processing. Urine samples were 
tested for proteins and red blood cells with standard 
dipsticks. Proteinuria was considered present if a subject 
had one or more crosses of protein. Blood samples were 
analyzed for serum creatinine, blood sugar and serum 
cholesterol levels. 
The glomerular filtration rate (GFR) was estimated using 
the Cockroft-Gault formula standardized for body surface 
area (BSA) and the four variable MDRD study equation. 
BSA was calculated according to Dubois and Dubois 
formula. CKD was defined as an estimated GFR of less 
than 60 ml/min/1.73 m2 and/or proteinuria. DM was 
considered present if random blood glucose level was ≥ 
200 mg/dl [8] or if the patient had a prior diagnosis of 
diabetes. Hypercholesterolemia was defined as random 
serum cholesterol ≥ 200 mg/dl. 
Subjects found to have any of the above conditions were 
referred to RUH for follow-up. A special clinic was 
arranged to accommodate the HyDRIT study participants 
and care was provided free of charge.
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The SPSS software version 15 was used to analyze the 
data. P values less than 0.05 were considered statistically 
significant.
Results
Out of 436 individuals approached, 426 (97.7%) 
responded to our questionnaire and had their 
anthropometric measures and blood pressure recorded. 
However, because of lack of some subjects’ consent and 
logistic and technical difficulties, only 273 blood and 
urine samples were available for analysis. In effect, only 
273 subjects were surveyed for the presence of CKD, 
DM and hypercholesterolemia.
Of those 273 individuals, 134 (49.1%) were males and 
139 (50.9%) were females. The mean age was 34.3 
years (SD: 12, range: 18-87). 103 individuals (37.9%) 
originally came from the central region of Sudan, 96 
(35.3%) from the west, 33 (12.1%) from the south, 28 
(10.3%) from the north, and 12 (4.4%) from the east. 
Seventy-two individuals (26.7%) were single whereas 
the remainder were previously or currently married. 
Eighty-one individuals (30.2%) were policemen and 
women, 83 (31%) were housewives and only 13 (4.9%) 
were unemployed. The remaining had different jobs; 
the majority working in private enterprises. Fifteen 
individuals (5.5%) were illiterate, 24 (8.8%) had 1-5 years 
of education, 37 (13.5%) had 6-9 years of education while 
195 (71.4%) had 10 or more years of education. Thirty 
(11%) were active smokers and 9 (3.3%) were previous 
smokers; 24 (8.8%) used tumbak (tobacco kept in the 
buccal mucus membranes for variable lengths of time). 
Only eight individuals (2.9%) reported alcohol drinking 
and none reported using illicit drugs. The prevalence of 
underweight, overweight and obesity was 9.9%, 30.4% 
and 15.4% respectively. Only one individual had a heart 
attack and stroke in the past.
Estimated GFR strata according to the five NKF-KDOQI 
categories are shown in comparison to US population 
(Table 1). 
The overall prevalence of CKD was 11% (30/273) using 
the standardized Cockroft-Gault equation and 7.7% 
(21/273) using the four variable MDRD equation. None 
of those subjects was aware of his kidney problem. 
According to the standardized Cockroft-Gault formula, 
5.1% (14/273) of subjects had proteinuria with an 
estimated GFR ≥ 60 ml/min/1.73 m² (corresponding to 
stages 1-2 CKD), while 5.9% (16/273) had an estimated 
GFR < 60 ml/min/1.73 m² (corresponding to stages 3-5 
CKD) including two subjects with proteinuria (Table 2). 
According to the MDRD formula, 4.7% (13/273) of 
subjects had proteinuria with an estimated GFR ≥ 60 ml/
min/1.73 m² (corresponding to stages 1-2 CKD), while 
2.9% (8/273) had an estimated GFR < 60 ml/min/1.73 
m² (corresponding to stages 3-5 CKD) including three 
subjects with proteinuria (Table 2).
Table 1:  Comparison of the prevalence of the five NKF-KDOQI GFR categories in our study population and the US adult 
population [1]
Estimated GFR  
(ml/min/1.73 m²)
HyDRIT study (%)  
Cockroft-Gault formula
HyDRIT study (%)  
MDRD formula
US population (%)  
MDRD formula
≥ 90 63 65.6 64.3
60-89 31.1 31.5 31.2
30-59 5.5 2.6 4.3
15-29 0 0 0.2
< 15 0.4 0.4 0.2
Table 2:  Comparison of the prevalence of the five NKF-KDOQI CKD stages in our study population and the US adult 
population [1]
CKD stage HyDRIT study (%)  
Cockroft-Gault formula
HyDRIT study (%)  
MDRD formula
US population (%)  
MDRD formula
Stage 1 or 2 5.1 4.7 6.3 
Stage 3 5.5 2.6 4.3
Stage 4 0 0 0.2
Stage 5 0.4 0.4 0.2
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Further analysis of potential risk factors was based on 
CKD identification by the standardized Cockroft-Gault 
formula. Fourteen (46.7%) of identified CKD cases were 
hypertensive; eight of them (57.1%) had a prior diagnosis 
of hypertension and seven were on antihypertensive 
medication. However, none of them had a controlled 
blood pressure of less than 130/80 mmHg.
Four of identified CKD cases (13.3%) were diabetic; 
three of them had a prior diagnosis of DM including 
two subjects on hypoglycemic agents. All of them had 
controlled blood sugar levels less than 160 mg/dl. 
Fourteen of screened individuals (5.1%) were found to 
be diabetic; eight of them (57.1%) had a prior diagnosis 
of DM, two of whom had their blood sugar controlled by 
diet, while the other six were on hypoglycemic agents. 
Only two of the six patients on hypoglycemic agents had 
blood sugar levels less than 160 mg/dl. Among the 14 
diabetic patients, four (28.6%) were identified to have 
CKD including two subjects with proteinuria (14.3%).
Twenty-nine of screened individuals (10.6%) had 
hypercholesterolemia; seven (24.1%) of them were 
identified to have CKD, including two subjects with 
proteinuria (6.9%). 
Age above 50 years, low educational level, hyper-
cholesterolemia and hypertension were significantly 
more common in the CKD group (Table 3). However, 
only age above 50 years and low educational level proved 
to be independent risk factors for CKD in multivariate 
analysis (Table 4).
This pilot study is the first step in a larger study of the 
prevalence of non-communicable diseases among an 
estimated seven thousands inhabitants in police housing 
complexes in Greater Khartoum. Our results show that 
this sample has prevalence rates of CKD, hypertension 
and DM similar to those in developed countries with 
national registries of renal patients [1-4].
The MDRD study equation was developed with the use of 
data from 1628 patients with CKD and was subsequently 
validated in numerous populations, including African 
Americans, Whites, and Asians. It estimates GFR adjusted 
for body surface area. The MDRD study equation is 
believed to be more accurate than either the use of the 
Table 3:  Risk factors for CKD using univariate analysis
Variable OR 95 % C.I. P value
Age above 50 years 13.5 5.1-35.8 0.00
Less than 10 years of education 5.2 2.3-11.6 0.00
Diabetes mellitus 3.6 1.1-12.2 0.05
Hypercholesterolemia 3.1 1.2-7.9 0.03
Underweight 2.6 1-7.2 0.06
Hypertension 2.4 1.1-5.3 0.02
Active smoking 2.3 0.8-6.1 0.09
Male gender 1.0 0.5-2.2 0.53
OR: odds ratio, CI: confidence interval
Table 4:  Risk factors for CKD using multinomial logistic regression analysis
Variable OR 95 % C.I. P value
Age above 50 years 5.4 1.6 – 18.4 0.01
Diabetes mellitus 3.8 0.8 – 19.6 0.12
Less than 10 years of education 3.0 1.1 – 8.1 0.03
Active smoking 3.0 1.0 – 9.5 0.06
Underweight 2.8 0.8 – 9.4 0.09
Hypertension 1.5 0.6 – 4.0 0.40
Hypercholesterolemia 1.4 0.4 – 4.9 0.62
Male gender 1.0 0.5-2.2 0.53
OR: odds ratio, CI: confidence interval
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Cockcroft-Gault equation or direct measurement of 
creatinine clearance [10]. For Blacks, the product is 
multiplied by 1.212 to compensate for a higher average 
serum creatinine level in Blacks, partly owing to increased 
muscle mass [10]. Sudan is a large country with diverse 
ethnicities ranging from Arabs to indigenous Africans. 
In general, people tend to have smaller body built and 
muscle mass than African Americans and they may not 
be considered equivalent to them. Using the four variable 
MDRD equation for GFR stratifications yielded a smaller 
number of patients, 8 (3%) as opposed to 16 (5.9%), with 
an estimated GFR less than 60 ml/min/1.73 m2 compared 
to the standardized Cockcroft-Gault formula. In the 
NHANES III study, the prevalence of individuals with 
an estimated GFR less than 60 ml/min/1.73m2 according 
to the MDRD formula was 4.5% compared to 7% when 
using the standardized Cockroft-Gault formula [1].
In spite of the small number of individuals who 
participated in our study, it gives comparable number of 
CKD patients as extrapolated from studies performed in 
the US, Europe and Australia [1-4]. If the present numbers 
reflect the picture of the whole country, approximately 
3-4 million individuals might have some degree of renal 
impairment. Sudanese health care institutions may not be 
able to support the heavy economic burden of providing 
renal replacement therapy (RRT) to all patients who need 
it. All Sudanese parties involved in this issue should 
begin an orchestrated effort to approach the problem of 
CKD.
Age above 50 years and low educational level were the 
only two factors that remained significantly associated 
with CKD in multivariate analysis. Low education may 
predispose to reluctance and noncompliance with medical 
care.  Although other factors, like tobacco consumption 
[11] and obesity [12] may confer an increased risk 
for CKD, their effect was not significant in our study 
participants. 
Given the considerable prevalence of hypertension in the 
HyDRIT study (27%), the level of unawareness was high 
(69.6%) [13]. Among the 14 individuals identified to have 
CKD, eight subjects were aware of their hypertension 
status and seven were on antihypertensive medication, 
but none had a controlled blood pressure of less than 
130/80 mmHg. For patients with CKD aggressive goals 
are currently recommended and antihypertensive therapy 
is given for both renal protection and cardiovascular 
protection, since CKD is associated with a marked 
increase in cardiovascular risk [14]. A reduction in blood 
pressure to less than 130/80 mmHg is recommended 
as per the Seventh Joint National Committee and the 
K/DOQI Clinical Practice Guidelines [15, 16]. 
The prevalence of DM among screened individuals 
was 5.1%. This figure is well above the WHO estimate 
of 3.4% in Sudan [17]. Among diabetics, 42.9% were 
unaware of their diabetic status. Almost half of those with 
a prior diagnosis of DM had their blood sugars controlled 
to less than 160 mg/dl by pharmacologic and non-
pharmacologic measures. The significant prevalence of 
DM is in conformity with that of overweight and obesity 
in our sample (45.8%). Eight (57.1%) of the diabetics 
were also hypertensive but none had their blood pressure 
controlled to less than130/80 mmHg. The currently 
recommended goal blood pressure is less than 130/80 
mmHg in all patients with DM [16]. Promoting healthy 
life-style changes including weight reduction should 
help in lowering the prevalence of DM, hypertension 
and their serious consequences in this population. DM 
is the most common cause of new patients requiring 
renal replacement therapy in the industrialized world, 
accounting for approximately 45, 36 and 22% of cases 
in the US, Germany and Australia, respectively [18]. 
In contradistinction to developed countries, chronic 
glomerulonephritis and interstitial nephritis are believed 
to be the principal causes of CKD in developing countries 
[19]. Despite the considerable prevalence of DM in our 
sample (5.1%), only 13.3% of patients with CKD had 
DM. This may indicate a more significant contribution 
by glomerulonephropathies to the causation of CKD, or 
simply reflect that the number of participants in our study 
was not high enough to detect such a relationship. 
Study limitations
The results in this pilot study should be taken with caution 
since the survey included a small number of paients 
belonging to a subset of the Sudanese community, and 
may not reflect the situation in the whole country.
Conclusion
To conclude, the prevalence of CKD in the study 
population seems to be comparable to other countries. 
The only identified independent risk factors were age 
above 50 years and low-educational level.
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